The At2g31350 Antibody (product code CSB-PA874425XA01DOA) is a research-grade antibody targeting the protein encoded by the AT2G31350 gene in Arabidopsis thaliana (thale cress). This gene, also known as GLX2-5, encodes a mitochondrial glyoxalase 2 (Glx II) critical for detoxifying reactive carbonyl compounds like methylglyoxal. The antibody is primarily used in biochemical studies to investigate protein expression, localization, and functional roles in plant stress responses.
The AT2G31350 gene encodes a mitochondrial glyoxalase 2, part of the glyoxalase pathway responsible for detoxifying methylglyoxal—a toxic byproduct of glycolysis. Key features include:
Metal Center: Accommodates diverse metal ions, with Fe(III)Zn(II) as the predominant configuration .
Function: Converts methylglyoxal to D-lactate via glutathione-dependent catalysis, mitigating oxidative stress .
Localization: Mitochondria, consistent with its role in detoxifying reactive carbonyls in cellular energy hubs .
| Gene Detail | Description |
|---|---|
| DB Identifier | AT2G31350 |
| Symbol | GLX2-5 |
| Pathway | Glyoxalase pathway (KEGG: K01069) |
| Ortholog Groups | KEGG Orthology (KO) |
While direct studies using the At2g31350 Antibody are not explicitly documented in the provided sources, its potential applications align with the gene’s known functions:
Oxidative Stress: Investigate Glx II expression under methylglyoxal-induced stress or abiotic conditions.
Protein Stability: Track post-translational modifications (e.g., metal center dynamics) under stress via Western blotting or immunoprecipitation.
Subcellular Localization: Confirm mitochondrial targeting using immunofluorescence or organelle fractionation.
Protein Interactions: Identify binding partners in the glyoxalase pathway (e.g., glyoxalase I or glutathione) via co-immunoprecipitation.
Metal Ion Specificity: Compare Fe(III)Zn(II) versus other metal configurations (e.g., Fe(III)Fe(III)) in catalysis efficiency.
Evolutionary Analysis: Cross-reactivity tests with orthologs in other plant species to study glyoxalase evolution.
Perform sequential validation using:
Knockout mutants (e.g., T-DNA insertion lines) as negative controls
Parallel detection with anti-HA tagged recombinant At2g31350 ( )
2D gel electrophoresis to confirm predicted molecular weight (35-40 kDa) and isoelectric point (pI 6.2)
Include:
Tissue-specific extraction controls (root vs. leaf mitochondria)
Co-analysis with glyoxalase I activity using spectrophotometric assays ( )
Use:
15-20 μg mitochondrial protein per lane
Prolonged transfer times (2 hr at 100V) for 35-40 kDa proteins
Chemiluminescent substrates with high sensitivity (e.g., ECL Prime)
Integrated workflow:
Quantify MG-H1 adducts using anti-MG-H1 antibodies (STA 011) ( )
Measure GLO2 enzymatic activity via spectrophotometric SLG hydrolysis assay
Correlate protein levels with:
Glutathione redox status (GSH:GSSG ratio)
ROS markers (H2O2, O2⁻)
Implement:
Laser-capture microdissection of root maturation zones
Subcellular fractionation validation (mitochondrial vs cytosolic)
Spatial expression mapping using ProAt2g31350:GUS lines
Critical factors:
Tissue-specific protease activity (add 2 mM PMSF in extraction buffer)
Organ-specific glycosylation patterns (use PNGase F treatment)
Mitochondrial integrity (verify via cytochrome c oxidase assay)
Multi-omics strategy:
Parallel measurement of:
Multivariate analysis using:
Partial Least Squares Regression
Pathway enrichment in MapMan
Experimental design:
Time-course analysis across developmental stages
Comparative treatments:
| Condition | MG Level | Expected ΔGLX2-5 |
|---|---|---|
| Control | 0.5 μM | Baseline |
| NaCl 150mM | 2.8 μM | +300% |
| Methylviologen 10μM | 4.1 μM | +450% |
Key findings: